| Term 
 | Definition 
 
        | anything with action similar to morphine |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | not used with precision - analgesic, CNS depressant anything capable of causing dependence - legal context |  | 
        |  | 
        
        | Term 
 
        | Endogenous Opioid Peptides |  | Definition 
 
        | enkephalins endorphins
 dynorphins
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Which one do opioids not interact with? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Action of opioid on Mu receptor |  | Definition 
 
        | activation include analgesia, respiratory depression, euphoria, sedation |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | activate mu and kappa morphine pro-type -strong opioid codiene - pro type mod - strong |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -Acts an antagonist to mu sites and agonist to kappa sites - Do no give with a pure opioid it will block the action |  | 
        |  | 
        
        | Term 
 
        | Agonist- Antagonist Drugs Pentazocine |  | Definition 
 
        | - Talwin - mild to moderate pain - activation  of Kappa sites produces analagesia, sedation, little resp depression - little euphoria, can produce anxiety at sub therapuetic levels - can trigger withdrawl in opioid dep patients - orally - 50 mg every 3-4 hours |  | 
        |  | 
        
        | Term 
 
        | Agonist-Antagonist Nalbuphine   |  | Definition 
 
        | - Nubain - when used in labor can cause bradycardia of fetus - supplied Iv, IM, Sq - Dose 10 mg every 3-6 hours |  | 
        |  | 
        
        | Term 
 
        | Agonist-Antagonist Butorphanol |  | Definition 
 
        | - Stadol - blocks mu stimulates kappa - ceiling effect less than 1/2 of morphine - increases cardiac work - IV, IM, Nasal spray - IV - 1-2 mg every 3-4, IM 2mg every3-4 - Used as nasal spray for migranes |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | - should be administered on a fixed schedule and given before pain returns |  | 
        |  | 
        
        | Term 
 
        | Opioid Withdrawl Reaction |  | Definition 
 
        | - Seen when given at high doses for over 20 days - withdraw slowly with tapering doses over 3 days Physical Dependence - abstinence syndrome Abuse- drug use that is inconsistent with medical or social norms Addiction- behaviour pattern characterized by continued use of psychoactive substance despite harm |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |  Meperidine ( Demerol)  less likely to depress fetal respiration |  | 
        |  | 
        
        | Term 
 
        | Myocardial Infarction Opioid |  | Definition 
 
        | - Morphine opioid of choice, also lowers BP and decrease cardiac work load |  | 
        |  | 
        
        | Term 
 
        | Opioid Antagonists Naloxone |  | Definition 
 
        | Naloxone ( Narcan) - structural analog of morphine acts as a competitive antagonist Reversal of Post operative Opioids - 0.1 to 0.2 mg IV every 2-3 minutes Opioid Overdose - 0.4 mg every 2-3 minutes Neonatal resp depression - 10 Mcg/ kg V |  | 
        |  | 
        
        | Term 
 
        | Opioid Antagonists Methylnaltrexone |  | Definition 
 
        | - Used of opioid induced constipation, selective mu antagonist - Does not readily cross blood brain barrier so it does not block opioid effect on the brain -SQ, half life 8 hours |  | 
        |  | 
        
        | Term 
 
        | Opioid Antagonist Alvimopan (Entereg) |  | Definition 
 
        | -selective Mu antagonist - approved for only short term use of opioid induced ileus - long term use associated with MI - 12 mg given 0.5 to 5 hours before surgery, then 12 mg 2 x day for a total of 15 doses |  | 
        |  | 
        
        | Term 
 
        | Nonopioid Central Acting Analgesics Tramadol ( Ultram) |  | Definition 
 
        | MOA- analog of codiene weak agonist of mu receptors, blocking uptake of norepinephrine and serotonin Peak in 2 hours with half life 5-6 hours hepatic metbolism - few side effects - Can enhance ETOH and benzodiazepines, interaction with MAO's, SSI, tricyclic antidepressants, triptans. |  | 
        |  | 
        
        | Term 
 
        | Non-Opioid Central Acting Analgesics Clonidine (Duraclon) |  | Definition 
 
        | - also treatment for HTN - for pain relief it is my epidural infusion MOA- alpha2-adrenergic agonist, binding with presynmaptic alpha receptors |  | 
        |  |